Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
25%
Ph not_applicable
1
25%
Ph phase_1
2
50%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Active, not recruiting1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
Phase 12 (50.0%)
N/A1 (25.0%)

Trials by Status

completed125%
active_not_recruiting125%
recruiting125%
withdrawn125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

NCT05743842
recruitingphase_1

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

NCT06432036
withdrawnphase_1

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

NCT05490381
completedearly_phase_1

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

NCT04976257

Clinical Trials (4)

Showing 4 of 4 trials
NCT05743842Not Applicable

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Active Not Recruiting
NCT06432036Phase 1

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

Recruiting
NCT05490381Phase 1

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

Withdrawn
NCT04976257Early Phase 1

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4